DNA METHYLATION/NEUROENDOCRINE DIFFERENTIATION--MARKING EARLY STATE LUNG CANCER

$0P50FY2002CANIH

Johns Hopkins University, Baltimore MD

Investigators

Stephen B Baylin

Linked publications, trials & patents

Paper 33740019 Paper 27729459 Paper 27637888 Paper 27552339 Paper 26988985 Paper 26317466 Paper 25668024 Paper 25651083 Paper 25474141 Paper 24830724 Paper 24828660 Paper 24614082 Paper 24600403 Paper 24583822 Paper 24486589 Paper 24463449 Paper 24382390 Paper 24162015 Paper 24158479 Paper 24088737 Paper 24045660 Paper 23921124 Paper 23859704 Paper 23546045 Paper 23425628 Paper 23364532 Paper 23291299 Paper 23182391 Paper 23072722 Paper 22941189 Paper 22919281 Paper 22707926 Paper 22653209 Paper 22586682 Paper 22510351 Paper 22496870 Paper 22495056 Paper 22439938 Paper 22269705 Paper 22136600 Paper 22132744 Paper 22039262 Paper 22005302 Paper 21936514 Paper 21896639 Paper 21888887 Paper 21768098 Paper 21539383 Paper 21504160 Paper 21447817 Paper 21402910 Paper 21248763 Paper 20697356 Paper 20682644 Paper 20562917 Paper 20534738 Paper 20507946 Paper 20460467 Paper 20446773 Paper 20364832 Paper 20360128 Paper 20332298 Paper 20124447 Paper 20122172 Paper 19904794 Paper 19903768 Paper 19826047 Paper 19443857 Paper 19351829 Paper 19350087 Paper 19027064 Paper 18829555 Paper 18539968 Paper 18487995 Paper 18451218 Paper 18413838 Paper 18337602 Paper 18308762 Paper 18056164 Paper 17822364 Paper 17761539 Paper 17456585 Paper 17406356 Paper 17404812 Paper 17360475 Paper 17342092 Paper 17147806 Paper 17097057 Paper 17065372 Paper 17047043 Paper 17020408 Paper 16968214 Trial NCT01578551 Trial NCT00255775 Patent 8216777 Patent 7749709 Patent 7348139 Patent 6500625 Patent 6251586 Patent 5994062

View original record on NIH RePORTER →